Agilent Announces Thought Leader Award to Peter Neubauer
03 Agosto 2023 - 9:00AM
Business Wire
Technical University of Berlin researcher recognized for his
innovative work in bioprocess engineering
Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter
Neubauer has been selected to receive a prestigious Agilent Thought
Leader Award. As Chair of Bioprocess Engineering at the Technical
University of Berlin, Dr. Neubauer leads innovative research to
identify new methods for more efficient bioprocess development,
including genetic, cultivation, and analytical tools, with a
particular focus on industrial-scale applications.
Automation and high throughput are important for the real-time
determination of critical quality attributes (CQAs), thus
optimizing biotechnological applications. To this end, substantial
resources are being directed toward developing process analytical
technology (PAT) – a mechanism for designing, analyzing, and
controlling pharmaceutical manufacturing processes by monitoring
parameters that impact quality – to ultimately minimize public
health risks.
Dr. Neubauer’s work orchestrates hardware, software, automation,
mathematical models, and AI to discover optimal conditions for PAT
end-to-end workflows. Integrating intelligent technologies and
automation into PAT solutions is a key factor for moving the
pharmaceutical industry toward optimized bioprocesses that improve
safety and reduce hands-on intervention. The Agilent Thought Leader
Award will support his ongoing research into understanding and
optimizing bioprocesses for difficult-to-express proteins and the
development of scale-up/scale-down strategies.
“We are truly grateful and excited that Agilent's award will
open up the opportunity to incorporate two-dimensional liquid
chromatography and mass spectrometry into our upcoming bioprocess
laboratory. The use of such leading-edge instrumentation is a
fundamental element in our journey towards achieving a higher level
in automated bioprocess development,” said Dr. Neubauer who
established and heads the KIWI-biolab as an International Future
Laboratory for AI for Intelligent Integrated Biolaboratories.
“Given our recent progress in seamlessly orchestrating all devices
required in the process, ranging from extensive analyte-specific
sample preparation to the management of big data, we feel ready to
conquer this next logical step of integration.”
“Agilent is pleased to grant this Thought Leader Award to Dr.
Neubauer to support his scientific developments in the biopharma
space,” said Sudharshana Seshadri, vice president and general
manager of Agilent’s Liquid Chromatography, Mass Spectrometry, and
Automation Divisions, and executive sponsor of the award. “His
important work will help the pharmaceutical industry optimize their
bioprocesses and accelerate improved healthcare worldwide.”
The Agilent Thought Leader Award program promotes fundamental
scientific advances by contributing financial support, products,
and expertise to the research of influential thought leaders in the
life sciences, diagnostics, and chemical analysis space. To learn
more, visit the Agilent Thought Leader Award website.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in
analytical and clinical laboratory technologies, delivering
insights and innovation that help our customers bring great science
to life. Agilent’s full range of solutions includes instruments,
software, services, and expertise that provide trusted answers to
our customers' most challenging questions. The company generated
revenue of $6.85 billion in fiscal 2022 and employs 18,000 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, please
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230803578963/en/
MEDIA CONTACT Naomi Goumillout Agilent Technologies
+1.978.314.1862 naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024